Indian Council of Medical Research’s (ICMR) approval for the country’s first self-use rapid antigen test for covid-19, CoviSelf. The approval followed an advisory by the apex biomedical research agency late Wednesday, allowing the use of self-testing kits even as it cautioned against its indiscriminate use. The test can be purchased for ₹250 without a prescription from local pharmacies and online channel partners, the Pune-based company said in a statement. Testing will be monitored using Mylab’s mobile phone application, through which users are advised to click a picture of the test strip after completing the procedure. Mint explains the modalities of the new testing kit and what it could mean in the battle against the pandemic.
2.jpg)
.jpg)
